| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20abbd7583e10e8847db70fd67cb7b88 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cecef8e56d88df6af505f3a988573e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cadb7f64edb336f4ed6e1144d286bb65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cde487c7936144fa897ec01259e945b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8ce5e7d29499ad882ee5e96aae3673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc42e8457ccbc4cb07108f9474a698d |
| publicationDate |
2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3028713-A1 |
| titleOfInvention |
Use of g-csf dimer in the treatment of neutropenia |
| abstract |
This invention relates to a use of G-CSF dimer in the treatment of neutropenia. In particular, the recombinant human G-CSF of the present invention can enhance the differentiation and development of neutrophils in animal, and thus effectively reduce the severity of the severe neutropenia and shorten the time of severe neutropenia for the post-chemotherapy cancer patients. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased, providing a better effect in the treatment of neutropenia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020165664-A1 |
| priorityDate |
2010-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |